247 related articles for article (PubMed ID: 8698499)
1. Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.
Konadu E; Shiloach J; Bryla DA; Robbins JB; Szu SC
Infect Immun; 1996 Jul; 64(7):2709-15. PubMed ID: 8698499
[TBL] [Abstract][Full Text] [Related]
2. Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam.
Konadu EY; Lin FY; Hó VA; Thuy NT; Van Bay P; Thanh TC; Khiem HB; Trach DD; Karpas AB; Li J; Bryla DA; Robbins JB; Szu SC
Infect Immun; 2000 Mar; 68(3):1529-34. PubMed ID: 10678970
[TBL] [Abstract][Full Text] [Related]
3. Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.
Polotsky VY; Robbins JB; Bryla D; Schneerson R
Infect Immun; 1994 Jan; 62(1):210-4. PubMed ID: 8262629
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.
Chu CY; Liu BK; Watson D; Szu SS; Bryla D; Shiloach J; Schneerson R; Robbins JB
Infect Immun; 1991 Dec; 59(12):4450-8. PubMed ID: 1937803
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.
Gupta RK; Egan W; Bryla DA; Robbins JB; Szu SC
Infect Immun; 1995 Aug; 63(8):2805-10. PubMed ID: 7542631
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines.
Konadu E; Robbins JB; Shiloach J; Bryla DA; Szu SC
Infect Immun; 1994 Nov; 62(11):5048-54. PubMed ID: 7927787
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
Taylor DN; Trofa AC; Sadoff J; Chu C; Bryla D; Shiloach J; Cohen D; Ashkenazi S; Lerman Y; Egan W
Infect Immun; 1993 Sep; 61(9):3678-87. PubMed ID: 8359890
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.
Ali A; An SJ; Cui C; Haque A; Carbis R
Hum Vaccin Immunother; 2014; 10(6):1494-8. PubMed ID: 24603090
[TBL] [Abstract][Full Text] [Related]
9. Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain.
Altman E; Chandan V; Harrison BA; Veloso-Pita R; Li J; KuoLee R; Chen W; Vérez-Bencomo V;
Vaccine; 2012 Nov; 30(50):7332-41. PubMed ID: 22534169
[TBL] [Abstract][Full Text] [Related]
10. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
[TBL] [Abstract][Full Text] [Related]
12. O:2-CRM(197) conjugates against Salmonella Paratyphi A.
Micoli F; Rondini S; Gavini M; Lanzilao L; Medaglini D; Saul A; Martin LB
PLoS One; 2012; 7(11):e47039. PubMed ID: 23144798
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of the O-acetylated O-polysaccharide isolated from Salmonella paratyphi A and used for vaccine preparation.
Ravenscroft N; Cescutti P; Gavini M; Stefanetti G; MacLennan CA; Martin LB; Micoli F
Carbohydr Res; 2015 Mar; 404():108-16. PubMed ID: 25665787
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.
Yu S; Gu XX
Infect Immun; 2005 May; 73(5):2790-6. PubMed ID: 15845482
[TBL] [Abstract][Full Text] [Related]
15. Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1.
Pozsgay V; Chu C; Pannell L; Wolfe J; Robbins JB; Schneerson R
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5194-7. PubMed ID: 10220442
[TBL] [Abstract][Full Text] [Related]
16. Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.
Boutonnier A; Villeneuve S; Nato F; Dassy B; Fournier JM
Infect Immun; 2001 May; 69(5):3488-93. PubMed ID: 11292781
[TBL] [Abstract][Full Text] [Related]
17. Attenuated
Liu Q; Li P; Luo H; Curtiss R; Kong Q
Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
[No Abstract] [Full Text] [Related]
18. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.
Jin Z; Chu C; Robbins JB; Schneerson R
Infect Immun; 2003 Sep; 71(9):5115-20. PubMed ID: 12933854
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.
Lagergard T; Shiloach J; Robbins JB; Schneerson R
Infect Immun; 1990 Mar; 58(3):687-94. PubMed ID: 2407652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
